GH1 and metabolic dysfunction-associated steatotic liver disease: Additionally, chronic liver diseases, including NAFLD, are linked to endocrine dysregulation, characterized by systemic insulin resistance, hyperinsulinemia, elevated growth hormone levels, and hyperestrogenism [22].